Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report

11 June 2021, Academic Emergency Medicine


Case of a previously healthy 16-year-old male who developed myopericarditis following the second dose of his Pfizer-BioNTech COVID-19 vaccine, with no other identified triggers. Cardiac magnetic resonance imaging showed normal biventricular volumes, morphology, and systolic function. However, there were signs of myocardial fibrosis, myocardial hyperemia, and a small pericardial effusion consistent with myopericarditis.

Download PDF

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s